Grafik für das Drucken der Seite Abbildung von Tiligada / Ennis | Histamine Receptors as Drug Targets | 1. Auflage | 2017 | beck-shop.de
eBook

Tiligada / Ennis

Histamine Receptors as Drug Targets

sofort lieferbar!

106,99 €

Preisangaben inkl. MwSt. Abhängig von der Lieferadresse kann die MwSt. an der Kasse variieren. Weitere Informationen

eBook. PDF

eBook

2017

517 S. XVI, 517 p. 138 illus., 93 illus. in color..

In englischer Sprache

Springer New York. ISBN 978-1-4939-6843-5

Das Werk ist Teil der Reihe: Methods in Pharmacology and Toxicology

Produktbeschreibung

This book illustrates the current state-of-the-art in histamine research, with a focus on the appropriate methodologies to investigate the pharmacological properties and the therapeutic exploitation of HRs and their ligands. In addition, the range of techniques described provides an introduction to complementary cross-methodological disciplines beyond these fields. This multi-disciplinary approach is required to define the 'decision gates' that determine the development of more effective and safer therapeutic options for many forms of highly prevalent and debilitating diseases, such as asthma, dementias, dermatitis, and arthritis. Written for the Methods in Pharmacology and Toxicology series, chapters concentrate on practical, hands-on protocols from experts in the techniques.

Authoritative and thorough, Histamine Receptors as Drug Targets seeks to aid pharmacologists, biochemists, drug discovery researchers, molecular biologists, chemists, toxicologists, lab scientists, medical doctors, principle investigators, research scientists, lab directors and technicians, as well as graduate students around the world in pursuing the study of this vital scientific area.

Topseller & Empfehlungen für Sie

Ihre zuletzt angesehenen Produkte

Autorinnen/Autoren

  • Rezensionen

    Dieses Set enthält folgende Produkte:
      Auch in folgendem Set erhältlich:
      • nach oben

        Ihre Daten werden geladen ...